We assessed the effectiveness of pericoital tenofovir gel , an antiviral microbicide , in preventing HSV-2 acquisition in a subgroup of 422 HSV-2-negative women enrolled in the Centre for the AIDS Programme of Research in South Africa ( CAPRISA ) 004 study , a double-blind , randomized , placebo-controlled trial .